<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
0074-5016-99
</NDCCode>
<PackageDescription>
4 TRAY in 1 CASE (0074-5016-99) / 90 VIAL in 1 TRAY / 1 VIAL, SINGLE-DOSE in 1 VIAL / 10 mL in 1 VIAL, SINGLE-DOSE
</PackageDescription>
<NDC11Code>
00074-5016-99
</NDC11Code>
<ProductNDC>
0074-5016
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Risankizumab
</NonProprietaryName>
<DosageFormName>
INJECTION, SOLUTION
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20240930
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
AbbVie Inc.
</LabelerName>
<SubstanceName>
RISANKIZUMAB
</SubstanceName>
<StrengthNumber>
600
</StrengthNumber>
<StrengthUnit>
mg/10mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Unfinished
</Status>
<LastUpdate>
2025-02-20
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
30-SEP-24
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>